168. Ehlers-Danlos syndrome Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 13 / Drugs : 21 - (DrugBank : 11) / Drug target genes : 11 - Drug target pathways : 103
Ehlers-Danlos syndrome and other diseases between which drug repositioning (DR) might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Score (Drug repositionability)
| ID | Diseases (Sorted by score) | Score |
|---|---|---|
| 168 | Ehlers-Danlos syndrome | - |
| 96 | Crohn disease | 9.000 |
| 113 | Muscular dystrophy | 7.232 |
| 46 | Malignant rheumatoid arthritis | 7.150 |
| 58 | Hypertrophic cardiomyopathy | 5.671 |
| 193 | Prader-Willi syndrome | 5.658 |
| 86 | Pulmonary arterial hypertension | 5.553 |
| 127 | Frontotemporal lobar degeneration | 4.300 |
| 36 | Epidermolysis bullosa | 4.245 |
| 107 | Juvenile idiopathic arthritis | 4.231 |
| 226 | Interstitial cystitis with Hunners ulcer | 4.188 |
| 70 | Spinal stenosis | 4.182 |
| 28 | Systemic amyloidosis | 4.182 |
| 51 | Scleroderma | 4.106 |
| 97 | Ulcerative colitis | 4.084 |
| 2 | Amyotrophic lateral sclerosis | 4.070 |
| 6 | Parkinson disease | 4.064 |
| 13 | Multiple sclerosis/Neuromyelitis optica | 4.045 |
| 1 | Spinal and bulbar muscular atrophy | 3.889 |
| 10 | Charcot-Marie-Tooth disease | 3.788 |
| 38 | Stevens-Johnson syndrome | 3.519 |
| 114 | Non-dystrophic myotonia syndrome | 3.395 |
| 256 | Muscle glycogenosis | 3.136 |
| 231 | Alpha-1-antitrypsin deficiency | 3.095 |
| 140 | Dorabe syndrome | 3.009 |
| 144 | Lennox-Gastaut syndrome | 3.005 |
| 298 | Hereditary pancreatitis | 2.987 |
| 53 | Sjogren syndrome | 2.980 |
| 156 | Rett syndrome | 2.922 |
| 84 | Sarcoidosis | 2.913 |
| 8 | Huntington disease | 2.910 |
| 34 | Neurofibromatosis | 2.905 |
| 299 | Cystic fibrosis | 1.062 |
| 232 | Carney complex | 1.000 |
| 191 | Werner syndrome | 1.000 |